129 related articles for article (PubMed ID: 38307573)
1. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
[TBL] [Abstract][Full Text] [Related]
2. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer.
Ma R; Okugawa Y; Shimura T; Yamashita S; Sato Y; Yin C; Uratani R; Kitajima T; Imaoka H; Kawamura M; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
Surg Oncol; 2024 Apr; 53():102044. PubMed ID: 38335851
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
[TBL] [Abstract][Full Text] [Related]
5. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
[TBL] [Abstract][Full Text] [Related]
6. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.
Iida H; Tani M; Komeda K; Nomi T; Matsushima H; Tanaka S; Ueno M; Nakai T; Maehira H; Mori H; Matsui K; Hirokawa F; Kaibori M; Kubo S
HPB (Oxford); 2022 Jan; 24(1):101-115. PubMed ID: 34244053
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.
Nakashima K; Haruki K; Kamada T; Takahashi J; Tsunematsu M; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
Am Surg; 2024 Apr; ():31348241248693. PubMed ID: 38644521
[TBL] [Abstract][Full Text] [Related]
8. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
[TBL] [Abstract][Full Text] [Related]
10. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery.
Feng J; Wang L; Yang X; Chen Q
Sci Rep; 2024 Jan; 14(1):713. PubMed ID: 38184747
[TBL] [Abstract][Full Text] [Related]
12. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery.
Takeda Y; Sugano H; Okamoto A; Nakano T; Shimoyama Y; Takada N; Imaizumi Y; Ohkuma M; Kosuge M; Eto K
Asian J Surg; 2024 Mar; ():. PubMed ID: 38538400
[TBL] [Abstract][Full Text] [Related]
13. The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Onodera A; Morita J; Hashimoto I; Ishiguro T; Endo K; Cho H; Onuma S; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1916-1922. PubMed ID: 35738628
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer.
Tsai YT; Ko CA; Chen HC; Hsu CM; Lai CH; Lee YC; Tsai MS; Chang GH; Huang EI; Fang KH
J Cancer; 2022; 13(10):3000-3012. PubMed ID: 36046647
[No Abstract] [Full Text] [Related]
15. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer.
Wang W; Gu J; Liu Y; Liu X; Jiang L; Wu C; Liu J
Cancer Manag Res; 2022; 14():2803-2812. PubMed ID: 36160036
[TBL] [Abstract][Full Text] [Related]
16. Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis.
Furukawa K; Tsunematsu M; Tanji Y; Ishizaki S; Akaoka M; Haruki K; Uwagawa T; Onda S; Matsumoto M; Ikegami T
Surg Oncol; 2023 Apr; 47():101911. PubMed ID: 36773544
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Morita J; Hashimoto I; Ishiguro T; Onodera A; Cho H; Endo K; Onuma S; Kano K; Hara K; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1896-1902. PubMed ID: 35738593
[TBL] [Abstract][Full Text] [Related]
19. Preoperative C-reactive protein to albumin ratio predicts anastomotic leakage after esophagectomy for thoracic esophageal cancer: a single-center retrospective cohort study.
Sugimoto A; Toyokawa T; Miki Y; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Muguruma K; Yashiro M; Ohira M
BMC Surg; 2021 Sep; 21(1):348. PubMed ID: 34548054
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer.
Zhuang J; Wang S; Wang Y; Wu Y; Hu R
Int J Gen Med; 2024; 17():997-1005. PubMed ID: 38505146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
